Submit Deal

Submit Deal

Cover Image Rachel McMinn

Rachel McMinn

Founder and CEO at NEUROGENE INC

Manager

Deal Bio

Total Deals2

Valued Deals2

Total Value£ 369 M

Avg. Deal Size£ 184 M

Market Context

Sort

16 Dec 2020|United States|Biotechnology

Target: NEUROGENE INC

Bidder: CASDIN CAPITAL

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

18 Jul 2023|United States|Biotechnology

Target: NEOLEUKIN THERAPEUTICS

Bidder: NEUROGENE INC

9 Service Providers

3 Target | 6 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 282 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite